Related references
Note: Only part of the references are listed.Brag2 differentially regulates β1-and β3-integrin-dependent adhesion in endothelial cells and is involved in developmental and pathological angiogenesis
Yosif Manavski et al.
BASIC RESEARCH IN CARDIOLOGY (2014)
Pharmacophoric Modifications Lead to Superpotent αvβ3 Integrin Ligands with Suppressed α5β1 Activity
Stefanie Neubauer et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Functionalizing αvβ3- or α5β1-Selective Integrin Antagonists for Surface Coating: A Method To Discriminate Integrin Subtypes In Vitro
Florian Rechenmacher et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2013)
Selective Imaging of the Angiogenic Relevant Integrins α5β1 and αvβ3
Stefanie Neubauer et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2013)
Integrin α5β1 Plays a Critical Role in Resistance to Temozolomide by Interfering with the p53 Pathway in High-Grade Glioma
Hana Janouskova et al.
CANCER RESEARCH (2012)
68Ga-NODAGA-RGD is a suitable substitute for 18F-Galacto-RGD and can be produced with high specific activity in a cGMP/GRP compliant automated process
Karolin Pohle et al.
NUCLEAR MEDICINE AND BIOLOGY (2012)
The Primacy of β1 Integrin Activation in the Metastatic Cascade
Hisashi Kato et al.
PLOS ONE (2012)
Integrins as therapeutic targets
Simon L. Goodman et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2012)
The role of β3-integrins in tumor angiogenesis: context is everything
Stephen D. Robinson et al.
CURRENT OPINION IN CELL BIOLOGY (2011)
Cilengitide: The First Anti-Angiogenic Small Molecule Drug Candidate. Design, Synthesis and Clinical Evaluation
Carlos Mas-Moruno et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2010)
The final steps of integrin activation: the end game
Sanford J. Shattil et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2010)
Integrins in cancer: biological implications and therapeutic opportunities
Jay S. Desgrosellier et al.
NATURE REVIEWS CANCER (2010)
Ligands for Mapping αvβ3-Integrin Expression in Vivo
Margret Schottelius et al.
ACCOUNTS OF CHEMICAL RESEARCH (2009)
Integrin signalling at a glance
David S. Harburger et al.
JOURNAL OF CELL SCIENCE (2009)
β1 integrin inhibition dramatically enhances radiotherapy efficacy in human breast cancer xenografts
Catherine C. Park et al.
CANCER RESEARCH (2008)
Inhibition of metastatic outgrowth from single dormant tumor cells by targeting the cytoskeleton
Dalit Barkan et al.
CANCER RESEARCH (2008)
Rational design of highly active and selective ligands for the α5β1 integrin receptor
Dominik Heckmann et al.
CHEMBIOCHEM (2008)
αvβ3 integrin and angiogenesis: a moody integrin in a changing environment
Kairbaan Hodivala-Dilke
CURRENT OPINION IN CELL BIOLOGY (2008)
68Ga- and 111In-labelled DOTA-RGD peptides for imaging of αvβ3 integrin expression
Clemens Decristoforo et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2008)
Three-dimensional MR mapping of angiogenesis with α5β1(αvβ3)-targeted theranostic nanoparticles in the MDA-MB-435 xenograft mouse model
Anne H. Schmieder et al.
FASEB JOURNAL (2008)
Caveolin-1-dependent β1 integrin endocytosis is a critical regulator of fibronectin turnover
Feng Shi et al.
JOURNAL OF CELL SCIENCE (2008)
Integrins in angiogenesis and lymphangiogenesis
Christie J. Avraamides et al.
NATURE REVIEWS CANCER (2008)
αVβ3 and α5B1 integrin recycling pathways dictate downstream Rho kinase signaling to regulate persistent cell migration
Dominic P. White et al.
JOURNAL OF CELL BIOLOGY (2007)
Positron emission tomography using [18F]Galacto-RGD identifies the level of integrin αvβ3 expression in man
Ambros J. Beer et al.
CLINICAL CANCER RESEARCH (2006)
Targeting RGD recognizing integrins: Drug development, biomaterial research, tumor imaging and targeting
A. Meyer et al.
CURRENT PHARMACEUTICAL DESIGN (2006)
Noninvasive visualization of the activated αvβ3 integrin in cancer patients by positron emission tomography and [18F]Galacto-RGD
R Haubner et al.
PLOS MEDICINE (2005)
[F-18]Galacto-RGD: Synthesis, radiolabeling, metabolic stability, and radiation dose estimates
R Haubner et al.
BIOCONJUGATE CHEMISTRY (2004)
Multimeric cyclic RGD peptides as potential tools for tumor targeting: Solid-phase peptide synthesis and chemoselective oxime ligation
G Thumshirn et al.
CHEMISTRY-A EUROPEAN JOURNAL (2003)
Integrins: Bidirectional, allosteric signaling machines
RO Hynes
CELL (2002)
Carbohydrate-based mimetics in drug design: Sugar amino acids and carbohydrate scaffolds
SAW Gruner et al.
CHEMICAL REVIEWS (2002)
Enhanced pathological angiogenesis in mice lacking beta(3) integrin or beta(3) and beta(5) integrins
LE Reynolds et al.
NATURE MEDICINE (2002)
Regulation of angiogenesis in vivo by ligation of integrin α5β1 with the central cell-binding domain of fibronectin
S Kim et al.
AMERICAN JOURNAL OF PATHOLOGY (2000)